AIM
Price
$2.40
Change
-$0.25 (-9.43%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
7.33M
BBOT
Price
$12.00
Change
+$1.35 (+12.68%)
Updated
Aug 18, 04:59 PM (EDT)
Capitalization
843.44M
16 days until earnings call
Interact to see
Advertisement

AIM vs BBOT

Header iconAIM vs BBOT Comparison
Open Charts AIM vs BBOTBanner chart's image
AIM ImmunoTech
Price$2.40
Change-$0.25 (-9.43%)
Volume$1.1K
Capitalization7.33M
BridgeBio Oncology Therapeutics
Price$12.00
Change+$1.35 (+12.68%)
Volume$700
Capitalization843.44M
AIM vs BBOT Comparison Chart in %
Loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIM vs. BBOT commentary
Aug 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Hold and BBOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 19, 2025
Stock price -- (AIM: $2.65 vs. BBOT: $10.65)
Brand notoriety: AIM and BBOT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 27% vs. BBOT: 85%
Market capitalization -- AIM: $7.33M vs. BBOT: $843.44M
AIM [@Biotechnology] is valued at $7.33M. BBOT’s [@Biotechnology] market capitalization is $843.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 0 FA rating(s) are green whileBBOT’s FA Score has 1 green FA rating(s).

  • AIM’s FA Score: 0 green, 5 red.
  • BBOT’s FA Score: 1 green, 4 red.
According to our system of comparison, BBOT is a better buy in the long-term than AIM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 4 TA indicator(s) are bullish while BBOT’s TA Score has 5 bullish TA indicator(s).

  • AIM’s TA Score: 4 bullish, 5 bearish.
  • BBOT’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, BBOT is a better buy in the short-term than AIM.

Price Growth

AIM (@Biotechnology) experienced а +6.00% price change this week, while BBOT (@Biotechnology) price change was +5.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.86%. For the same industry, the average monthly price growth was +22.78%, and the average quarterly price growth was +23.29%.

Reported Earning Dates

BBOT is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+8.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBOT($843M) has a higher market cap than AIM($7.33M). BBOT YTD gains are higher at: 1.429 vs. AIM (-86.616).
AIMBBOTAIM / BBOT
Capitalization7.33M843M1%
EBITDAN/AN/A-
Gain YTD-86.6161.429-6,063%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt2.52MN/A-
FUNDAMENTALS RATINGS
AIM: Fundamental Ratings
AIM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AIMBBOT
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
47%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
14%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 4 days ago
8%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
24%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
7%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 4 days ago
16%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 5 days ago
27%
View a ticker or compare two or three
Interact to see
Advertisement
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY17.450.37
+2.17%
Oatly Group AB
BANC15.79N/A
N/A
Banc of California
LSBK12.66-0.07
-0.55%
Lake Shore Bancorp Inc
EQH53.90-0.74
-1.35%
Equitable Holdings
NCNA3.73-0.42
-10.12%
NuCana plc

AIM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AIM has been loosely correlated with CVAC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AIM jumps, then CVAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIM
1D Price
Change %
AIM100%
+3.11%
CVAC - AIM
44%
Loosely correlated
-0.54%
URGN - AIM
39%
Loosely correlated
-1.84%
SGMT - AIM
30%
Poorly correlated
-11.53%
IBIO - AIM
28%
Poorly correlated
N/A
MEIP - AIM
24%
Poorly correlated
-0.20%
More

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and COCP have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and COCP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
+6.61%
COCP - BBOT
25%
Poorly correlated
+0.89%
CORT - BBOT
21%
Poorly correlated
-0.35%
AIM - BBOT
3%
Poorly correlated
+3.11%
IMA - BBOT
1%
Poorly correlated
-3.99%
LIMN - BBOT
0%
Poorly correlated
-2.91%
More